SEC Form 4 · accession 0000891293-15-000025

CTI BIOPHARMA CORP · CTIC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, Global Medical Affairs · Director

Period of report

Jul 24, 2015

Accepted (ET)

Jul 24, 2015 · 6:29 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000891293

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jul 24, 2015	S	3,200	$1.88	D	1,287,719	D
Common Stock	Jul 24, 2015	S	700	$1.89	D	1,287,019	D
Common Stock	Jul 24, 2015	S	100	$1.895	D	1,286,919	D
Common Stock	Jul 24, 2015	S	1,400	$1.90	D	1,285,519	D
Common Stock	Jul 24, 2015	S	900	$1.91	D	1,284,619	D
Common Stock	Jul 24, 2015	S	400	$1.915	D	1,284,219	D
Common Stock	Jul 24, 2015	S	2,700	$1.92	D	1,281,519	D
Common Stock	Jul 24, 2015	S	1,500	$1.925	D	1,280,019	D
Common Stock	Jul 24, 2015	S	3,200	$1.93	D	1,276,819	D
Common Stock	Jul 24, 2015	S	600	$1.935	D	1,276,219	D
Common Stock	Jul 24, 2015	S	300	$1.94	D	1,275,919	D

No Table II lines on this filing.